… pulmonary exacerbations in CF. In this review, the efficacy and safety of the currently available
inhaled antibiotics … Moreover, the effects of long-term inhaled antibiotic therapy for chronic …

… The first report of inhaled antibiotic use in CF appeared in the … use of inhaled antibiotics in
the CF population. The development of inhaled antibiotics has primarily focused on antibiotics …

… inhaled antibiotics for the treatment of pulmonary exacerbations in people with cystic
fibrosis… trial of inhaled antibiotics for the management of pulmonary exacerbations (NCT03066453). …

… In summary, dornase alfa, hypertonic saline, and mannitol are inhaled agents that have
each been shown to demonstrate pulmonary benefits in CF by improving mucus clearance, …

… Additionally, inhaled liposomal amikacin and murepavadin are … inhaled antibiotics will
be summarized. Combination therapy and the strategies to select an optimal inhaled antibiotic …

… Experience with using inhaled antibiotics has varied. Aerosolized antibiotics have been …
patients with cystic fibrosis, tuberculosis, non-cystic fibrosis bronchiectasis, or COPD (Table 2). …

… antibiotic therapy for non-cystic fibrosis bronchiectasis (NCFB) has yet to be determined.
A meta-analysis was conducted to evaluate the efficacy and safety of inhaled antibiotics in …

… Further, we speculated that adherence to inhaled antibiotics was challenged by the … of
inhaled antibiotic use, this study describes the use of different types of inhaled antibiotics against …

… This study is the first to compare safety and effectiveness of inhaled antibiotics in non-hospitalized
adults with NCFB, depending on the aerosol generating devices. Both DPI and SVN …

… pulmonary infections in people with CF. This article reviews the role of inhaled antibiotics
in … fibrosis patients who receive cystic fibrosis transmembrane conductance regulator (CFTR) …